Skip to main content

Advertisement

SpringerLink
Log in

Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer

  • Original Article
  • Published:
Tumor Biology

Abstract

Prostate cancer is the most commonly diagnosed cancer among men and is the second leading cause of cancer-associated deaths among men in the world. Unfortunately, treatment failures are common due to the metastasis and chemoresistance, but the underlying molecular mechanism remains unclear. Accumulating evidence has indicated that the deregulation of DNA-binding protein High Mobility Group A2 (HMGA2) is associated with the development and progression of cancer. This study aimed to explore the expression of HMGA2 in prostate cancer tissues and its correlation to the clinical pathology of prostate cancer, and to discuss the role of HMGA2 in the development of prostate cancer. The results showed that the expression of HMGA2 messenger RNA (mRNA) in the prostate cancer tissues and cells was significantly higher than that in normal prostate tissues and cells (p < 0.05), and the positive expression rate of HMGA2 mRNA in the prostate cancer tissues from patients with positive lymph node metastasis or with high Gleason grade was significantly higher than that from patients with negative lymph node metastasis or with low Gleason grade (p < 0.05). In order to explore the role of HMGA2 in prostate cancer, the expression of HMGA2 in the human prostate cancer PC3 cell line was downregulated by RNA interference. Then, the changes in proliferation, apoptosis, invasion, and migration of PC3 cells were examined by MTT test, PI staining, Annexin V-FITC staining, and Transwell chamber assay. Results showed that the abilities of proliferation, invasion, and migration were suppressed in HMGA2 knockdown PC3 cells, and the abilities of apoptosis were enhanced in HMGA2 knockdown PC3 cells. The expression of cyclin A and vimentin was downregulated in HMGA2 knockdown PC3 cells, and the expression of caspase 3 and E-cadherin was upregulated in HMGA2 knockdown PC3 cells. Taken together, the overexpression of HMGA2 in prostate cancer might be related to the tumorigenesis, invasion, and metastasis of prostate cancer, the downregulation of HMGA2 could inhibit cellular proliferation, invasion, and metastasis, and improve cellular apoptosis in prostate cancer, which might be a potential target for the treatment of prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. James ND, Spears MR, Clarke NW, Dearnaley DP, De Bono JS, Gale J, et al. Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: data from 917 patients in the control arm of the stampede trial (mrc pr08, cruk/06/019). Eur Urol. 2014. doi:10.1016/j.eururo.2014.1009.1032.

    Google Scholar 

  2. Zhang T, Zhang L, Yuan Q, Wang X, Zhang Y, Wang J, et al. The noninvasive detection of rarbeta2 promoter methylation for the diagnosis of prostate cancer. Cell Biochem Biophys. 2015;71:925–30.

    Article  CAS  PubMed  Google Scholar 

  3. Kiljunen T, Kangasmaki A, Aaltonen A, Kairemo K, Partanen K, Joensuu G, et al. Vmat technique enables concomitant radiotherapy of prostate cancer and pelvic bone metastases. Acta Oncol. 2015;54(6):847–53.

  4. Li D, Zhao LN, Zheng XL, Lin P, Lin F, Li Y, et al. Sox2 is involved in paclitaxel resistance of the prostate cancer cell line pc-3 via the pi3k/akt pathway. Mol Med Rep. 2014;10:3169–76.

    CAS  PubMed  Google Scholar 

  5. Patrikidou A, Loriot Y, Eymard JC, Albiges L, Massard C, Ileana E, et al. Who dies from prostate cancer? Prostate Cancer Prostatic Dis. 2014;17:348–52.

    Article  CAS  PubMed  Google Scholar 

  6. Shi X, Tian B, Ma W, Zhang N, Qiao Y, Li X, et al. A novel anti-proliferative role of hmga2 in induction of apoptosis through caspase 2 in primary human fibroblast cells. Biosci Rep. 2015;35(1). doi:10.1042/BSR20140112.

  7. Reeves R. Molecular biology of hmga proteins: hubs of nuclear function. Gene. 2001;277:63–81.

    Article  CAS  PubMed  Google Scholar 

  8. Hammond SM, Sharpless NE. Hmga2, micrornas, and stem cell aging. Cell. 2008;135:1013–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kim TH, Song JY, Park H, Jeong JY, Kwon AY, Heo JH, et al. Mir-145, targeting high-mobility group a2, is a powerful predictor of patient outcome in ovarian carcinoma. Cancer Lett. 2015;356:937–45.

    Article  CAS  PubMed  Google Scholar 

  10. Lee J, Ha S, Jung CK, Lee HH. High-mobility-group a2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition. Int J Oncol. 2015. doi:10.3892/ijo.2015.2947.

    Google Scholar 

  11. Dirat B, Ader I, Golzio M, Massa F, Mettouchi A, Laurent K, et al. Inhibition of the gtpase rac1 mediates the antimigratory effects of metformin in prostate cancer cells. Mol Cancer Ther. 2015;14:586–96.

    Article  CAS  PubMed  Google Scholar 

  12. Xia YY, Yin L, Tian H, Guo WJ, Jiang N, Jiang XS, et al. Hmga2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma. OncoTargets Ther. 2015;8:169–76.

    Article  CAS  Google Scholar 

  13. Kaur H, Hutt-Cabezas M, Weingart MF, Xu J, Kuwahara Y, Erdreich-Epstein A, et al. The chromatin-modifying protein hmga2 promotes atypical teratoid/rhabdoid cell tumorigenicity. J Neuropathol Exp Neurol. 2015;74:177–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ding X, Wang Y, Ma X, Guo H, Yan X, Chi Q, et al. Expression of hmga2 in bladder cancer and its association with epithelial-to-mesenchymal transition. Cell Prolif. 2014;47:146–51.

    Article  CAS  PubMed  Google Scholar 

  15. Bai YH, Wang JP, Yang M, Zeng Y, Jiang HY. Sirna-hmga2 weakened ages-induced epithelial-to-mesenchymal transition in tubular epithelial cells. Biochem Biophys Res Commun. 2015;457:730–5.

    Article  CAS  PubMed  Google Scholar 

  16. Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH, Moustakas A. Hmga2 and smads co-regulate snail1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem. 2008;283:33437–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Song HM, Lee JE, Kim JH. Ubiquitin c-terminal hydrolase-l3 regulates emt process and cancer metastasis in prostate cell lines. Biochem Biophys Res Commun. 2014;452:722–7.

    Article  CAS  PubMed  Google Scholar 

  18. Yu KR, Park SB, Jung JW, Seo MS, Hong IS, Kim HS, et al. Hmga2 regulates the in vitro aging and proliferation of human umbilical cord blood-derived stromal cells through the mtor/p70s6k signaling pathway. Stem Cell Res. 2013;10:156–65.

    Article  CAS  PubMed  Google Scholar 

  19. Shlapobersky M, Sanders R, Clark C, Spector DH. Repression of hmga2 gene expression by human cytomegalovirus involves the ie2 86-kilodalton protein and is necessary for efficient viral replication and inhibition of cyclin a transcription. J Virol. 2006;80:9951–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Tessari MA, Gostissa M, Altamura S, Sgarra R, Rustighi A, Salvagno C, et al. Transcriptional activation of the cyclin a gene by the architectural transcription factor hmga2. Mol Cell Biol. 2003;23:9104–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Natural Science Foundation of China (No. 81402226).

Author information

Authors and Affiliations

  1. Department of Rehabilitation, Affiliated Hospital of Nantong University, 20 West Temple Road, Nantong, Jiangsu Province, 226001, People’s Republic of China

    Junyan Cai, Guangyu Shen & Su Liu

  2. Orthopedics Department, The Fourth Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, People’s Republic of China

    Qingbing Meng

Authors
  1. Junyan Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guangyu Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Su Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qingbing Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Junyan Cai.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cai, J., Shen, G., Liu, S. et al. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer. Tumor Biol. 37, 699–707 (2016). https://doi.org/10.1007/s13277-015-3853-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3853-9

Keywords

Search

Navigation